New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2012
16:16 EDTAZN, STP, NSRGY, TRGT, YGE, MYGN, TSL, RIO, BHP, TIFOn The Fly: Closing Wrap
Stocks on Wall Street were lower on concerns of slowing growth in China. The futures barely reacted to February U.S. housing data, which showed starts were lower than expected but building permits were higher. The futures action led to a lower open for the broader market. The averages found a level in the first 30 minutes of trading where they sat and eventually began to drift higher. The market moved generally higher until the last hour of the session but the averages were never able to retake the baseline to continue their six day winning streak... ECONOMIC EVENTS: In the U.S., homebuilders began construction on a seasonally adjusted annual rate of 698,000 homes in February, down 1.1% from a month ago. Building permits jumped 5.1%, versus expectations for an increase of 0.6%. In China, a report said that home prices dropped in 45 Chinese cities last month and the country increased its gas and diesel prices for the second time in less than six weeks... MARKET NEWS: BHP Billiton (BHP) was widely quoted as stating that Chinese iron ore demand growth was "flattening," but the company came out and said that the slowdown had been discussed before and was not new information. Also, both BHP and rival Rio Tinto (RIO) confirmed plans to expand production in China even further. Still, BHP's confirmation along with other signals of a slowdown in China was attributed as a significant catalyst for today's market pull-back... Saudi Arabia said it is ready to meet any shortfalls in global oil supplies which, along with China's news, caused oil prices to fall 2%, weighing on the Energy sector of the S&P... Amazon.com (AMZN) moved up 3.67% following its $775M purchase of Kiva Systems, a maker of robots and other material handling technology... MAJOR MOVERS: Among the notable gainers was Tiffany (TIF), up $4.59, or 6.68%, to $73.27, after its earnings missed expectations but its FY12 guidance beat the Street's view. Also higher were a number of Chinese solar companies, including Yingli Green Energy (YGE), up 46c, or 12.07%, to $4.27, Suntech (STP), up 44c, or 14.06%, to $3.57, and Trina Solar (TSL), up 61c, or 7.85%, to $8.38, following the U.S. Commerce Department's decision to impose tariffs of less than 5% on the companies, which was well below the 20% to 30% that was forecast by some analysts. Noteworthy losers included Targacept (TRGT), down $2.22, or 29.96%, to $5.19, after it abandoned plans to seek approval for a depression drug it was developing in partnership with AstraZeneca (AZN), and Myriad Genetics (MYGN), down $1.33, or 5.19%, to $24.31, after the Supreme Court ruled that two patents held by Nestle (NSRGY) for certain personalized medicine products are invalid because the patents utilize "laws of nature" without adding significant additional features to those laws... INDICES: The Dow fell 68.94, or 0.52%, to 13,170.19; the Nasdaq lost 4.17, or 0.14%, to 3,074.15; and the S&P 500 dropped 4.23, or 0.30%, to 1,405.52.
News For BHP;RIO;TIF;YGE;STP;TSL;TRGT;AZN;MYGN;NSRGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 19, 2015
10:23 EDTTIFHigh option volume stocks
Subscribe for More Information
08:37 EDTAZNNektar and Daiichi Sankyo to commercialize Movantik in the U.S.
Subscribe for More Information
March 18, 2015
11:29 EDTTSLSolar sector could get new boost from China raising solar energy targets
Subscribe for More Information
09:08 EDTTSLSentiment towards China solar names improving, says Roth Capital
After China raised its 2015 solar installation target, Roth Capital says that the country could significantly increase its 2020 solar target, boosting China solar stocks further. Roth identifies .Daqo New Energy (DQ), JA Solar (JASO), JinkoSolar (JKS), and Trina Solar (TSL) as the names in its coverage most likely to benefit directly from such a revision. It keeps Buy ratings on all the stocks named.
06:30 EDTYGE, TSLChina raises 2015 solar energy target, Barron's says
China increased its 2015 solar energy installation target to 17.8 gigawatts from 15 gigawatts previously, according to Barron's.Additionally, Beijing abandoned its previous practice of setting targets for both large scale utility solar facilities and rooftop projects, which should help Chinese solar companies, Barron's quoted Deutsche Bank as saying. Chinese solar stocks rallied in New York yesterday. Companies in the sector include JinkoSolar (JKS) Trina Solar (TSL) Canadian Solar (CSIQ),, Yingli Green Energy (YGE), and JA Solar (JASO). Reference Link
March 17, 2015
14:10 EDTAZNIGI Laboratories recent sell-off a buying opportunity, says Craig-Hallum
Subscribe for More Information
13:14 EDTBHPBHP Billiton upgraded to Buy from Neutral at Citigroup
07:18 EDTMYGNMyriad Genetics announces collaboration expansion with BioMarin
Myriad Genetics (MYGN) announced an expansion of the company's collaboration with BioMarin Pharmaceutical (BMRN). Under the expanded collaboration, BioMarin will use Myriad's myChoice HRD companion diagnostic test to prospectively identify patients with metastatic breast, ovarian and potentially other tumor types that may be sensitive to talazoparib. Financial terms were not disclosed.
05:51 EDTBHPBHP Billiton's South32 demerger to cost $738M
Subscribe for More Information
March 16, 2015
14:10 EDTTIFTiffany March volatility elevated into Q3 and outlook
Tiffany March call option implied volatility is at 67, April is at 31, May is at 26, August is at 25; compared to its 26-week average of 26 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on March 20.
10:02 EDTRIO, BHPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:07 EDTBHPBHP Billiton downgraded to Neutral from Overweight at HSBC
Subscribe for More Information
08:10 EDTRIORio Tinto downgraded to Neutral from Overweight at HSBC
Subscribe for More Information
07:30 EDTAZNAmerican College of Cardiology to hold an expo
Subscribe for More Information
06:11 EDTYGEYingli Green Energy begins construction of 50 MW plant in Hubei Province
Yingli Green Energy announced that it has begun construction of a 50 MW solar power plant on former mining lands in in Huangshi City, Hubei Province, China. It is the first project developed by Yingli on land that has been degraded by mining activities. The 50 MW power plant occupies over 100 hectares of land in western Huangshi City, a region known for its rich mineral resources and extensive mining operations. The project will contain about 170,000 YGE 72 Cell Series multicrystalline solar panels that are expected to generate approximately 55,000 megawatt-hours of clean electricity annually, which will offset the consumption of nearly 22,000 tons of coal and the emission of over 50,000 tons of carbon into the atmosphere. The system is scheduled to interconnect with the local utility grid and begin operations in Q4.
March 13, 2015
11:45 EDTMYGNMyriad Genetics management to meet with Stephens
Meeting to be held in Portland, Oregon on March 17-18 hosted by Stephens.
11:19 EDTAZNBioMarin rallies amid positive call on DMD drug timeline, takeover rumor
The shares of drug maker BioMarin (BMRN) are climbing after research firm Jefferies quoted a regulatory expert as saying that the company's drisapersen drug has a good chance of being approved on an accelerated basis by the FDA. Drisapersen is a treatment for Duchenne Muscular Dystrophy, or DMD. WHAT'S NEW: "There is a strong possibility" that the FDA will grant accelerated approval to drisapersen because there is currently no approved drug for the treatment of DMD, Jefferies analyst Eun Yang quoted the expert as saying. The expert is also optimistic about the outlook for accelerated approval because she had a good experience working with BioMarin while she was with the FDA and because BioMarin has a favorable track record with the FDA, according to Yang. There is a 60% chance that drisapersen will be approved by the end of this year and the stock can rise to $155, versus its current level of about $121.50, if that does occur, the analyst stated. Yang's price target on the stock increased to $135 from $125 and the analyst kept a Buy rating on the shares. WHAT'S NOTABLE: Pharmaceutical giant AstraZeneca (AZN) has been rumored to be interested in buying BioMarin for $175 per share in cash, British newspaper Daily Mail reported. , Piper Jaffray analyst Joshua Schimmer wrote in a note to investors this morning that BioMarin, along with Vertex (VRTX) and Incyte (INCY), have a "clear path" to joining the group of companies with market caps of over $10B projected to deliver greater than 20% EPS CAGR, which the analyst identified as a set of criteria that has previously pointed to companies that make good potential takeover targets. PRICE ACTION: In mid-morning trading, BioMarin climbed nearly 4% to $120.
09:49 EDTMYGNUBS life science tools/diagnostics analyst has analyst/industry conference call
Subscribe for More Information
08:07 EDTAZNAstraZeneca rumored to have BioMarin 'on shopping list,' Daily Mail says
Subscribe for More Information
06:32 EDTBHPU.S. looking into importing ferroalloy from BHP plant, Reuters says
The Department of Commerce is looking into inexpensive ferroalloy imports from a BHP Billiton plant in Australia, reports Reuters, citing the Department of Commerce. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use